Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    TRACON Pharmaceuticals In...

    OTC: TCON · Real-Time Price · USD
    0.03
    -0.00 (-6.83%)
    At close: Mar 06, 2025, 3:00 PM

    TRACON Pharmaceuticals Statistics

    Share Statistics

    TRACON Pharmaceuticals has 3.41M shares outstanding. The number of shares has increased by 27.2% in one year.

    Shares Outstanding

    n/a
    		 3.41M

    Shares Change (YoY)

    n/a
    		 27.2%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 9.91%

    Shares Floating

    n/a
    		 3.35M

    Failed to Deliver (FTD) Shares

    n/a
    		 4

    FTD / Avg. Volume

    n/a
    		 0.01%

    Short Selling Information

    The latest short interest is 166.13K, so undefined% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 166.13K

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 4.96%

    Short Ratio (days to cover)

    n/a
    		 0.95

    Valuation Ratios

    The PE ratio is -1.59 and the forward PE ratio is -0.17. TRACON Pharmaceuticals's PEG ratio is 0.02.

    PE Ratio

    n/a
    		 -1.59

    Forward PE

    n/a
    		 -0.17

    PS Ratio

    n/a
    		 0.47

    Forward PS

    n/a
    		 0

    PB Ratio

    n/a
    		 -7.06

    P/FCF Ratio

    n/a
    		 1.55

    PEG Ratio

    n/a
    		 0.02
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for TRACON Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.89, with a Debt / Equity ratio of -1.2.

    Current Ratio

    n/a
    		 0.89

    Quick Ratio

    n/a
    		 0.89

    Debt / Equity

    n/a
    		 -1.2

    Debt / EBITDA

    n/a
    		 -0.14

    Debt / FCF

    n/a
    		 0.26

    Interest Coverage

    n/a
    		 -0.94

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $708,529.41

    Profits Per Employee

    n/a
    		 $-211,058.82

    Employee Count

    n/a
    		 17

    Asset Turnover

    n/a
    		 1.19

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -99.43% in the last 52 weeks. The beta is 1.42, so TRACON Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.42

    52-Week Price Change

    n/a
    		 -99.43%

    50-Day Moving Average

    n/a
    		 0.03

    200-Day Moving Average

    n/a
    		 0.15

    Relative Strength Index (RSI)

    n/a
    		 43.66

    Average Volume (20 Days)

    n/a
    		 69,607

    Income Statement

    In the last 12 months, TRACON Pharmaceuticals had revenue of 12.04M and earned -3.59M in profits. Earnings per share was -2.2.

    Revenue

    n/a
    		 12.04M

    Gross Profit

    n/a
    		 12.03M

    Operating Income

    n/a
    		 -6.9M

    Net Income

    n/a
    		 -3.59M

    EBITDA

    n/a
    		 -6.88M

    EBIT

    n/a
    		 3.72M

    Earnings Per Share (EPS)

    n/a
    		 -2.2
    Full Income Statement

    Balance Sheet

    The company has 8.56M in cash and 968K in debt, giving a net cash position of 7.6M.

    Cash & Cash Equivalents

    n/a
    		 8.56M

    Total Debt

    n/a
    		 968K

    Net Cash

    n/a
    		 7.6M

    Retained Earnings

    n/a
    		 -240.5M

    Total Assets

    n/a
    		 7.4M

    Working Capital

    n/a
    		 -3.38M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 3.68M and capital expenditures 0, giving a free cash flow of 3.68M.

    Operating Cash Flow

    n/a
    		 3.68M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 3.68M

    FCF Per Share

    n/a
    		 2.25
    Full Cash Flow Statement

    Margins

    Gross margin is 99.88%, with operating and profit margins of -57.27% and -29.79%.

    Gross Margin

    n/a
    		 99.88%

    Operating Margin

    n/a
    		 -57.27%

    Pretax Margin

    n/a
    		 -29.79%

    Profit Margin

    n/a
    		 -29.79%

    EBITDA Margin

    n/a
    		 -57.15%

    EBIT Margin

    n/a
    		 -57.27%

    FCF Margin

    n/a
    		 30.52%

    Dividends & Yields

    TCON does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for TCON.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Apr 10, 2024. It was a backward split with a ratio of 1:20.

    Last Split Date

    n/a
    		 Apr 10, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:20

    Scores

    Altman Z-Score

    n/a
    		 -44.21

    Piotroski F-Score

    n/a
    		 5

    Add to Watchlist